Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/14518
|
| Title: | Aryl hydrocarbon receptor deficiency augments dysregulated microangiogenesis and diabetic retinopathy |
| Authors: | Lee, WJ;Lin, KH;Wang, JS;Sheu, WH;Shen, CC;Yang, CN;Wu, SM;Shen, LW;Lee, SH;Lai, DW;Lan, KL;Tung, CW;Liu, SH;Sheu, ML |
| Contributors: | Institute of Biotechnology and Pharmaceutical Research |
| Abstract: | Diabetic retinopathy (DR) is a pathophysiologic vasculopathic process with obscure mechanisms and limited effective therapeutic strategies. Aryl hydrocarbon receptor (AhR) is an important regulator of xenobiotic metabolism and an environmental sensor. The aim of the present study was to investigate the role of AhR in the development of DR and elucidate the molecular mechanism of its downregulation. DR was evaluated in diabetes-induced retinal injury in wild type and AhR knockout (AhR-/-) mice. Retinal expression of AhR was determined in human donor and mice eyes by immunofluorescence since AhR activity was examined in diabetes. AhR knockout (AhRKO) mice were used to induce diabetes with streptozotocin, high-fat diet, or genetic double knockout with diabetes spontaneous mutation (Leprdb) (DKO; AhR-/-×Leprdb/db) for investigating structural, functional, and metabolic abnormalities in vascular and epithelial retina. Structural molecular docking simulation was used to survey the pharmacologic AhR agonists targeting phosphorylated AhR (Tyr245). Compared to diabetic control mice, diabetic AhRKO mice had aggravated alterations in retinal vasculature that amplified hallmark features of DR like vasopermeability, vascular leakage, inflammation, blood-retinal barrier breakdown, capillary degeneration, and neovascularization. AhR agonists effectively inhibited inflammasome formation and promoted AhR activity in human retinal microvascular endothelial cells and pigment epithelial cells. AhR activity and protein expression was downregulated, resulting in a decrease in DNA promoter binding site of pigment epithelium-derived factor (PEDF) by gene regulation in transcriptional cascade. This was reversed by AhR agonists. Our study identified a novel of DR model that target the protective AhR/PEDF axis can potentially maintain retinal vascular homeostasis, providing opportunities to delay the development of DR. |
| Date: | 2022-09-21 |
| Relation: | Biomedicine and Pharmacotherapy. 2022 Sep 21;155:Article number 113725. |
| Link to: | http://dx.doi.org/10.1016/j.biopha.2022.113725 |
| JIF/Ranking 2023: | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0753-3322&DestApp=IC2JCR |
| Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:000863304900004 |
| Cited Times(Scopus): | https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85138503414 |
| Appears in Collections: | [童俊維] 期刊論文
|
Files in This Item:
| File |
Description |
Size | Format | |
|---|
| PUB36152407.pdf | | 19289Kb | Adobe PDF | 166 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|
